valproic acid has been researched along with Cutaneous T-Cell Lymphoma in 1 studies
Valproic Acid: A fatty acid with anticonvulsant and anti-manic properties that is used in the treatment of EPILEPSY and BIPOLAR DISORDER. The mechanisms of its therapeutic actions are not well understood. It may act by increasing GAMMA-AMINOBUTYRIC ACID levels in the brain or by altering the properties of VOLTAGE-GATED SODIUM CHANNELS.
valproic acid : A branched-chain saturated fatty acid that comprises of a propyl substituent on a pentanoic acid stem.
Excerpt | Relevance | Reference |
---|---|---|
"To evaluate the activity and safety of hydralazine and valproate (Transkrip) in cutaneous T-cell lymphoma (CTCL)." | 9.24 | Efficacy of hydralazine and valproate in cutaneous T-cell lymphoma, a phase II study. ( Candelaria, M; Cervera, E; Dueñas-González, A; Espinoza-Zamora, JR; Labardini-Méndez, J; López-González, C; Lozano-Zavaleta, V; Sosa-Espinoza, A; Toledano-Cuevas, DV; Vieyra-García, M; Zapata-Canto, N, 2017) |
"To evaluate the activity and safety of hydralazine and valproate (Transkrip) in cutaneous T-cell lymphoma (CTCL)." | 5.24 | Efficacy of hydralazine and valproate in cutaneous T-cell lymphoma, a phase II study. ( Candelaria, M; Cervera, E; Dueñas-González, A; Espinoza-Zamora, JR; Labardini-Méndez, J; López-González, C; Lozano-Zavaleta, V; Sosa-Espinoza, A; Toledano-Cuevas, DV; Vieyra-García, M; Zapata-Canto, N, 2017) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Espinoza-Zamora, JR | 1 |
Labardini-Méndez, J | 1 |
Sosa-Espinoza, A | 1 |
López-González, C | 1 |
Vieyra-García, M | 1 |
Candelaria, M | 1 |
Lozano-Zavaleta, V | 1 |
Toledano-Cuevas, DV | 1 |
Zapata-Canto, N | 1 |
Cervera, E | 1 |
Dueñas-González, A | 1 |
1 trial available for valproic acid and Cutaneous T-Cell Lymphoma
Article | Year |
---|---|
Efficacy of hydralazine and valproate in cutaneous T-cell lymphoma, a phase II study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Disease- | 2017 |